United States - English - NLM (National Library of Medicine)

strides pharma science limited - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae andhemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcu

United Arab Emirates - English - MOHAP (Ministry of Health & Prevention) - وزارة الصحة ووقاية المجتمع.الإمارات

alphamed drug store jordan - 200 ml bag - infusion - 400 mg/200 ml - infections-antibacterial

United States - English - NLM (National Library of Medicine)

amneal pharmaceuticals ny llc - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae , mycoplasma pneumoniae (eaton agent, and klebsiella sp. ) - skin and soft tissue infections caused by streptococcus pyogenes , staphylococcus aureaus . (tetracyclines are not the drugs of choice in the treatment of any type of staphylococcal infections.) - infections caused by rickettsia including rocky mountain spotted fever, typhus group infections, q fever, rickettsialpox. - psittacosis caused by chlamydophila psittaci . - infections caused by chlamydia trachomatis such as uncomplicated urethral, endocervical or rectal infections, inclusion conjunctivitis, trachoma, and lymphogranuloma venereum. - granuloma inquinale caused by klebsiella granulomatis . - relapsing fever caused by borrelia sp. - bartonellosis caused by bartonella bacilliformis . - chancroid caused by hemophilus ducreyi . - tularemia caused by francisella tularensis . - plaque caused by yersinia pestis . - cholera caused by vibrio cholerae . - brucellosis caused by brucella species (tetracycline may be used in conjunction with an aminoglycoside). - infections due to campylobacter fetus . - as adjunctive therapy in intestinal amebiasis caused by entamoeba histolytica . - urinary tract infections caused by susceptible strains of escherichia coli , klebsiella , etc. - other infections caused by susceptible gram-negative organisms such as e. coli , enterobacter aerogenes , shigella sp. , acinetobacter sp. , klebsiella sp. , and bacteroides sp . - in severe acne, adjunctive therapy with tetracycline may be useful. when penicillin is contraindicated, tetracyclines are alternative drugs in the treatment of the following infections: - syphilis and yaws caused by treponema pallidum and pertenue , respectively, - vincent’s infection caused by fusobacterium fusiforme , - infections caused by neisseria gonorrhoeae , - anthrax caused by bacillus anthracis , - infections due to listeria monocytogenes , - actinomycosis caused by actinomyces species, - infections due to clostridium species. this drug is contraindicated in persons who have shown hypersensitivity to any of the tetracyclines.

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

madunga vetagro centre ltd, tanzania - oxytetracycline injection 10% liquid injection - solution for intramuscular injection - 10

United States - English - NLM (National Library of Medicine)

norbrook laboratories limited - oxytetracycline (unii: x20i9en955) (oxytetracycline - unii:x20i9en955), flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - oxytetracycline 300 mg in 1 ml - for the treatment of bacterial pneumonia associated with pasteurella spp. and for the control of associated pyrexia in beef and non-lactating dairy cattle. do not use in animals showing hypersensitivity to either flunixin meglumine or oxytetracycline.

United States - English - NLM (National Library of Medicine)

heritage pharmaceuticals inc. - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of achromycin v (tetracycline hcl capsules, usp) and other antibacterial drugs, achromycin v (tetracycline hcl capsules, usp) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. achromycin v (tetracycline hcl capsules, usp) is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: achromycin v (tetracycline hcl capsules, usp) should not be used for streptococcal disease unless the organism ha

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - tetracycline hydrochloride - oral tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - tetracycline hydrochloride - oral tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - tetracycline hydrochloride - oral tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - tetracycline hydrochloride - oral tablet - 250mg